| Year |
Citation |
Score |
| Low-probability matches (unlikely to be authored by this person) |
| 2023 |
Ibrahim A, Wang F, Gary Hollenbeck R, Martinez MN, Fahmy R, Hoag SW. Development and Validation of a Stability-indicating UPLC-DAD Method for the Simultaneous Determination of Ivermectin and Praziquantel in Pharmaceutical Tablets and Dissolution Media. Aaps Pharmscitech. 24: 211. PMID 37821763 DOI: 10.1208/s12249-023-02656-y |
0.01 |
|
| 2023 |
Helal NA, Martinez MN, Longstaff DG, Mohamed EM, Rahman Z, Khan MA, Nutan MTH. Development and Validation of Discriminatory In-vitro Release Method for Intramammary Drug Product. Pharmaceutical Research. PMID 37783927 DOI: 10.1007/s11095-023-03609-7 |
0.01 |
|
| 2023 |
Martinez MN, Zhao F, Longstaff DG, Gabriel JJ, Coffey MJ. Evaluating the solubility of compounds intended for intramammary infusion based upon tests conducted across a range of milk matrices. Plos One. 18: e0288780. PMID 37478109 DOI: 10.1371/journal.pone.0288780 |
0.01 |
|
| 2023 |
Sahoo DK, Martinez MN, Dao K, Gabriel V, Zdyrski C, Jergens AE, Atherly T, Iennarella-Servantez CA, Burns LE, Schrunk D, Volpe DA, Allenspach K, Mochel JP. Canine Intestinal Organoids as a Novel In Vitro Model of Intestinal Drug Permeability: A Proof-of-Concept Study. Cells. 12. PMID 37174669 DOI: 10.3390/cells12091269 |
0.01 |
|
| 2023 |
Martinez MN, Gao S. Evaluation of product bioequivalence when subject blood volume necessitates limited sampling strategies. Journal of Veterinary Pharmacology and Therapeutics. PMID 37010032 DOI: 10.1111/jvp.13125 |
0.01 |
|
| 2023 |
Greene JM, Martinez MN. Using simulations to explore the potential effect of disease and inflammation on the frequency of violative flunixin residues in cattle. Journal of Veterinary Pharmacology and Therapeutics. PMID 36633943 DOI: 10.1111/jvp.13112 |
0.01 |
|
| 2022 |
Jelliffe R, Liu J, Drusano GL, Martinez MN. Individualized Patient Care Through Model-Informed Precision Dosing: Reflections on Training Future Practitioners. The Aaps Journal. 24: 117. PMID 36380020 DOI: 10.1208/s12248-022-00769-z |
0.01 |
|
| 2022 |
Martinez MN, Miller RA, Martín-Jiménez T, Sharkey MJ. Application of pharmacokinetic/pharmacodynamic concepts to the development of treatment regimens for sporadic canine urinary tract infections: Challenges and paths forward. Journal of Veterinary Pharmacology and Therapeutics. PMID 35906854 DOI: 10.1111/jvp.13088 |
0.01 |
|
| 2022 |
Martinez MN, Sinko B, Wu F, Flanagan T, Borbás E, Tsakalozou E, Giacomini KM. A Critical Overview of the Biological Effects of Excipients (Part I): Impact on Gastrointestinal Absorption. The Aaps Journal. 24: 60. PMID 35501614 DOI: 10.1208/s12248-022-00711-3 |
0.01 |
|
| 2022 |
Martinez MN, Wu F, Sinko B, Brayden DJ, Grass M, Kesisoglou F, Stewart A, Sugano K. A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development. The Aaps Journal. 24: 61. PMID 35501528 DOI: 10.1208/s12248-022-00713-1 |
0.01 |
|
| 2022 |
Martinez MN, Papich MG, Fahmy R. Impact of gastrointestinal differences in veterinary species on the oral drug solubility, in vivo dissolution, and formulation of veterinary therapeutics. Admet & Dmpk. 10: 1-25. PMID 35360673 DOI: 10.5599/admet.1140 |
0.01 |
|
| 2022 |
Gabriel V, Zdyrski C, Sahoo DK, Dao K, Bourgois-Mochel A, Atherly T, Martinez MN, Volpe DA, Kopper J, Allenspach K, Mochel JP. Canine Intestinal Organoids in a Dual-Chamber Permeable Support System. Journal of Visualized Experiments : Jove. PMID 35311824 DOI: 10.3791/63612 |
0.01 |
|
| 2021 |
Kopper JJ, Iennarella-Servantez C, Jergens AE, Sahoo DK, Guillot E, Bourgois-Mochel A, Martinez MN, Allenspach K, Mochel JP. Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach. Frontiers in Toxicology. 3: 773953. PMID 35295115 DOI: 10.3389/ftox.2021.773953 |
0.01 |
|
| 2021 |
Prescott JF, Martinez MN, Turnidge J, Page SW. The publication of studies involving the use of human critically important antimicrobial agents in veterinary species. Journal of Veterinary Pharmacology and Therapeutics. PMID 34378797 DOI: 10.1111/jvp.13005 |
0.01 |
|
| 2021 |
Martinez MN, Mochel JP, Neuhoff S, Pade D. Comparison of Canine and Human Physiological Factors: Understanding Interspecies Differences that Impact Drug Pharmacokinetics. The Aaps Journal. 23: 59. PMID 33907906 DOI: 10.1208/s12248-021-00590-0 |
0.01 |
|
| 2020 |
Martinez MN, Gao S. Evaluation of partial area under the curve in bioequivalence studies using destructive sampling design. Journal of Veterinary Pharmacology and Therapeutics. PMID 33615485 DOI: 10.1111/jvp.12934 |
0.01 |
|
| 2020 |
Martinez MN, Soback S. An introduction to the JVPT special issue on antimicrobial drugs. Journal of Veterinary Pharmacology and Therapeutics. PMID 32997371 DOI: 10.1111/jvp.12908 |
0.01 |
|
| 2020 |
Martinez MN, Greene J, Kenna L, Kissell L, Kuhn M. The impact of infection and inflammation on drug metabolism, active transport, and systemic drug concentrations in veterinary specie. Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 32503881 DOI: 10.1124/dmd.120.090704 |
0.01 |
|
| 2020 |
Martinez MN, Jelliffe RW, Proost JH. Expert Discussion of the Role of Rate Constant Versus Clearance Approaches to Define Drug Pharmacokinetics: Theoretical and Clinical Considerations. The Aaps Journal. 22: 25. PMID 31907706 DOI: 10.1208/s12248-019-0407-x |
0.01 |
|
| 2020 |
Martinez MN, Mochel JP, Pade D. Considerations in the extrapolation of drug toxicity between humans and dogs Current Opinion in Toxicology. 98-105. DOI: 10.1016/J.Cotox.2020.05.005 |
0.01 |
|
| 2019 |
Martinez MN, El-Kattan A, Awji E, Papich M. Reconciling Human-Canine Differences in Oral Bioavailability: Looking beyond the Biopharmaceutics Classification System. The Aaps Journal. 21: 99. PMID 31396733 DOI: 10.1208/s12248-019-0364-4 |
0.01 |
|
| 2019 |
Mzyk DA, Bublitz CM, Martinez MN, Davis JL, Baynes RE, Smith GW. Impact of bovine respiratory disease on the pharmacokinetics of danofloxacin and tulathromycin in different ages of calves. Plos One. 14: e0218864. PMID 31233558 DOI: 10.1371/journal.pone.0218864 |
0.01 |
|
| 2019 |
Tyson GH, Ayers S, Lam C, Miller RA, Martinez MN. Eukaryotic cell culture media affects macrolide MICs but not resistance interpretations for foodborne pathogens. Journal of Global Antimicrobial Resistance. PMID 31176074 DOI: 10.1016/j.jgar.2019.05.025 |
0.01 |
|
| 2019 |
Pade D, Jamei M, Turner DB, Mistry B, Martinez MN. Danazol Oral Absorption Modelling in the Fasted Dog: An Example of Mechanistic Understanding of Formulation Effects on Drug Pharmacokinetics. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 31150808 DOI: 10.1016/J.Ejpb.2019.05.024 |
0.01 |
|
| 2019 |
Martinez MN, Watts JL, Gilbert JM. Questions associated with the development of novel drugs intended for the treatment of bacterial infections in veterinary species. Veterinary Journal (London, England : 1997). 248: 79-85. PMID 31113568 DOI: 10.1016/J.Tvjl.2019.04.009 |
0.01 |
|
| 2019 |
Martinez MN, Bhoopathy S, Carlert S, Cirit M, Fahmy R, Flanagan T, Forbes B, Jamei M, Khan MA, Lukacova V, Mochel JP, Pepin X, Pade D, Reppas C, Sinko PJ, et al. Workshop Report: USP Workshop on Exploring the Science of Drug Absorption Dissolution Technologies. 26: 38-66. DOI: 10.14227/Dt260319P38 |
0.01 |
|
| 2019 |
Fahmy R, Martinez MN. Primer on the Science of In Vitro Dissolution Testing of Oral Dosage Forms and Factors Influencing its Biological Relevance Dissolution Technologies. 26: 14-26. DOI: 10.14227/DT260119P14 |
0.01 |
|
| 2018 |
Mzyk DA, Bublitz CM, Hobgood GD, Martinez MN, Smith GW, Baynes RE. Effect of age on the pharmacokinetics and distribution of tulathromycin in interstitial and pulmonary epithelial lining fluid in healthy calves. American Journal of Veterinary Research. 79: 1193-1203. PMID 30372149 DOI: 10.2460/ajvr.79.11.1193 |
0.01 |
|
| 2018 |
Mzyk DA, Bublitz CM, Hobgood GD, Martinez MN, Davis JL, Smith GW, Baynes RE. Effect of age on plasma protein binding of several veterinary drugs in dairy calves 2. Research in Veterinary Science. 121: 59-64. PMID 30359812 DOI: 10.1016/j.rvsc.2018.09.004 |
0.01 |
|
| 2018 |
Myers MJ, Martinez M, Li F, Howard K, Yancy HF, Troutman L, Sharkey M. Impact of ABCB1 genotype in Collies on the pharmacokinetics of R- and S-fexofenadine. Journal of Veterinary Pharmacology and Therapeutics. PMID 30020547 DOI: 10.1111/jvp.12696 |
0.01 |
|
| 2018 |
Martinez MN, Zhao X. A Simple Approach for Comparing the In Vitro Dissolution Profiles of Highly Variable Drug Products: a Proposal. The Aaps Journal. 20: 78. PMID 29942983 DOI: 10.1208/s12248-018-0238-1 |
0.01 |
|
| 2018 |
Martinez MN, Court MH, Fink-Gremmels J, Mealey KL. Population variability in animal health: Influence on dose-exposure-response relationships: Part I: Drug metabolism and transporter systems. Journal of Veterinary Pharmacology and Therapeutics. PMID 29917248 DOI: 10.1111/jvp.12670 |
0.01 |
|
| 2018 |
Martinez MN, Gehring R, Mochel JP, Pade D, Pelligand L. Population variability in animal health: Influence on dose-exposure-response relationships: Part II: Modelling and simulation. Journal of Veterinary Pharmacology and Therapeutics. PMID 29806231 DOI: 10.1111/Jvp.12666 |
0.01 |
|
| 2018 |
Dong Y, Qu H, Pavurala N, Wang J, Sekar V, Martinez M, Fahmy R, Ashraf M, Cruz CN, Xu X. Formulation Characteristics and In Vitro Release Testing of Cyclosporine Ophthalmic Ointments. International Journal of Pharmaceutics. PMID 29684560 DOI: 10.1016/j.ijpharm.2018.04.042 |
0.01 |
|
| 2017 |
Turnidge JD, Martinez MN. Proposed method for estimating clinical cut-off (COCL) values: An attempt to address challenges encountered when setting clinical breakpoints for veterinary antimicrobial agents. Veterinary Journal (London, England : 1997). 228: 33-37. PMID 29153105 DOI: 10.1016/j.tvjl.2017.10.004 |
0.01 |
|
| 2017 |
Martinez MN, Bartholomew MJ. What Does It "Mean"? A Review of Interpreting and Calculating Different Types of Means and Standard Deviations. Pharmaceutics. 9. PMID 28406450 DOI: 10.3390/pharmaceutics9020014 |
0.01 |
|
| 2017 |
Apley M, Crist B, Fellner V, Gonzalez M, Hunter R, Martinez M, Messenheimer J, Modric S, Papich M, Parr A, Riviere J, Marques M. Determination of Thermodynamic Solubility of Active Pharmaceutical Ingredients for Veterinary Species: A New USP General Chapter Dissolution Technologies. 24: 36-39. DOI: 10.14227/Dt240117P36 |
0.01 |
|
| 2017 |
Apley M, Crist B, Gonzalez M, Hunter R, Martinez M, Modric S, Papich M, Parr A, Riviere J, Marques M. Solubility Criteria for Veterinary Drugs Dissolution Technologies. 24: 22-35. DOI: 10.14227/Dt240117P22 |
0.01 |
|
| 2016 |
Stern ST, Martinez MN, Stevens DM. When is it Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics? Drug Metabolism and Disposition: the Biological Fate of Chemicals. PMID 27670412 DOI: 10.1124/dmd.116.073148 |
0.01 |
|
| 2016 |
Dickinson PA, Kesisoglou F, Flanagan T, Martinez MN, Mistry HB, Crison JR, Polli JE, Cruañes MT, Serajuddin AT, Müllertz A, Cook JA, Selen A. Optimizing Clinical Drug Product Performance: Applying Biopharmaceutics Risk Assessment Roadmap (BioRAM) and the BioRAM Scoring Grid. Journal of Pharmaceutical Sciences. PMID 27659159 DOI: 10.1016/J.Xphs.2016.07.024 |
0.01 |
|
| 2016 |
Mistry B, Patel N, Jamei M, Rostami-Hodjegan A, Martinez MN. Examining the Use of a Mechanistic Model to Generate an In Vivo/In Vitro Correlation: Journey Through a Thought Process. The Aaps Journal. PMID 27312260 DOI: 10.1208/s12248-016-9930-1 |
0.01 |
|
| 2016 |
Martinez M, Mistry B, Lukacova V, Polli JE, Hoag SW, Dowling T, Kona R, Fahmy R. Erratum to: Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin. The Aaps Journal. PMID 27215600 DOI: 10.1208/s12248-016-9933-y |
0.01 |
|
| 2016 |
Martinez M, Mistry B, Lukacova V, Polli J, Hoag S, Dowling T, Kona R, Fahmy R. Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin. The Aaps Journal. PMID 27116024 DOI: 10.1208/S12248-016-9913-2 |
0.01 |
|
| 2016 |
Qiu J, Martinez M, Tiwari R. Evaluating In Vivo-In Vitro Correlation Using a Bayesian Approach. The Aaps Journal. PMID 26896256 DOI: 10.1208/s12248-016-9880-7 |
0.01 |
|
| 2015 |
Oswald H, Sharkey M, Pade D, Martinez MN. Canine gastrointestinal physiology: Breeds variations that can influence drug absorption. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 26409436 DOI: 10.1016/J.Ejpb.2015.09.009 |
0.01 |
|
| 2015 |
Myers MJ, Martinez M, Li H, Qiu J, Troutman L, Sharkey M, Yancy HF. Influence of ABCB1 Genotype in Collies on the Pharmacokinetics and Pharmacodynamics of Loperamide in a Dose-Escalation Study. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 43: 1392-407. PMID 26153274 DOI: 10.1124/dmd.115.063735 |
0.01 |
|
| 2015 |
Papich MG, Martinez MN. Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls. The Aaps Journal. 17: 948-64. PMID 25916691 DOI: 10.1208/s12248-015-9743-7 |
0.01 |
|
| 2015 |
Martinez MN, Fahmy R. Demonstrating comparative in vitro bioequivalence for animal drug products through chemistry and manufacturing controls and physicochemical characterization: a proposal. The Aaps Journal. 17: 307-12. PMID 25609223 DOI: 10.1208/s12248-014-9702-8 |
0.01 |
|
| 2015 |
Kona R, Fahmy RM, Claycamp G, Polli JE, Martinez M, Hoag SW. Quality-by-design III: application of near-infrared spectroscopy to monitor roller compaction in-process and product quality attributes of immediate release tablets. Aaps Pharmscitech. 16: 202-16. PMID 25319052 DOI: 10.1208/S12249-014-0180-1 |
0.01 |
|
| 2014 |
Selen A, Dickinson PA, Müllertz A, Crison JR, Mistry HB, Cruañes MT, Martinez MN, Lennernäs H, Wigal TL, Swinney DC, Polli JE, Serajuddin AT, Cook JA, Dressman JB. The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance. Journal of Pharmaceutical Sciences. 103: 3377-97. PMID 25256402 DOI: 10.1002/Jps.24162 |
0.01 |
|
| 2013 |
Martinez MN, Antonovic L, Court M, Dacasto M, Fink-Gremmels J, Kukanich B, Locuson C, Mealey K, Myers MJ, Trepanier L. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics. Drug Metabolism Reviews. 45: 218-30. PMID 23432217 DOI: 10.3109/03602532.2013.765445 |
0.01 |
|
| 2012 |
Martinez MN, Papich MG, Drusano GL. Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target. Antimicrobial Agents and Chemotherapy. 56: 2795-805. PMID 22371890 DOI: 10.1128/Aac.05360-11 |
0.01 |
|
| 2011 |
Martinez MN. Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems. The Aaps Journal. 13: 632-49. PMID 21971647 DOI: 10.1208/s12248-011-9303-8 |
0.01 |
|
| 2011 |
Antonovic L, Martinez M. Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going? Future Medicinal Chemistry. 3: 855-79. PMID 21644832 DOI: 10.4155/fmc.11.37 |
0.01 |
|
| 2011 |
Martinez MN. Welcome to the animal pharmaceuticals special focus. Future Medicinal Chemistry. 3: 845-6. PMID 21644829 DOI: 10.4155/fmc.11.56 |
0.01 |
|
| 2010 |
Martinez MN, Lindquist D, Modric S. Terminology challenges: defining modified release dosage forms in veterinary medicine. Journal of Pharmaceutical Sciences. 99: 3281-90. PMID 20213837 DOI: 10.1002/jps.22095 |
0.01 |
|
| 2010 |
Martinez M, Silley P. Antimicrobial drug resistance. Handbook of Experimental Pharmacology. 227-64. PMID 20204590 DOI: 10.1007/978-3-642-10324-7_10 |
0.01 |
|
| 2010 |
Martinez MN, Rathbone MJ, Burgess D, Huynh M. Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products. Journal of Controlled Release : Official Journal of the Controlled Release Society. 142: 2-7. PMID 19808069 DOI: 10.1016/J.Jconrel.2009.09.028 |
0.01 |
|
| 2009 |
Martinez MN, Papich MG. Factors influencing the gastric residence of dosage forms in dogs. Journal of Pharmaceutical Sciences. 98: 844-60. PMID 18661535 DOI: 10.1002/jps.21499 |
0.01 |
|
| 2009 |
Rathbone MJ, Martinez MN, Huynh M, Burgess D. CRS/AAPS Joint Workshop on Critical Variables in the In Vitro and In Vivo Performance of Parenteral Sustained-Release Products Dissolution Technologies. 16: 55-56. DOI: 10.14227/Dt160209P55 |
0.01 |
|
| 2008 |
Martinez M, Rathbone M, Burgess D, Huynh M. In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. Journal of Controlled Release : Official Journal of the Controlled Release Society. 129: 79-87. PMID 18514351 DOI: 10.1016/J.Jconrel.2008.04.004 |
0.01 |
|
| 2008 |
Fleischer S, Sharkey M, Mealey K, Ostrander EA, Martinez M. Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model. The Aaps Journal. 10: 110-9. PMID 18446511 DOI: 10.1208/S12248-008-9011-1 |
0.01 |
|
| 2007 |
Toutain PL, Bousquet-Mélou A, Martinez M. AUC/MIC: a PK/PD index for antibiotics with a time dimension or simply a dimensionless scoring factor? The Journal of Antimicrobial Chemotherapy. 60: 1185-8. PMID 17932075 DOI: 10.1093/jac/dkm360 |
0.01 |
|
| 2007 |
Martinez MN, Bonate P, Chapman RL, De Groot A, D'Souza S, Ghilazi N, Gray V, Gupta VK, Huynh-Ba K, Iyer S, Jayatilaka A, Joshi A, Karnes HT, Khan M, Liu P, et al. Corrigendum: 2007 highlights of advances in the pharmaceutical sciences: An American Association of Pharmaceutical Scientists (AAPS) perspective The Aaps Journal. 9: E328-E328. DOI: 10.1208/aapsj0903038c |
0.01 |
|
| 2007 |
Martinez MN, Bonate P, Chapman RL, De Groot A, D'Souza S, Ghilazi N, Gray V, Gupta VK, Huynh-Ba K, Iyer S, Jayatilaka A, Joshi A, Thomas Karnes H, Khan M, Liu P, et al. 2007 highlights of advances in the pharmaceutical sciences: An American Association of Pharmaceutical Scientists (AAPS) perspective The Aaps Journal. 9: E219-E226. DOI: 10.1208/Aapsj0902024 |
0.01 |
|
| 2007 |
BRAYDEN D, MARTINEZ M. Prediction of therapeutic and drug delivery outcomes using animal models☆ Advanced Drug Delivery Reviews. 59: 1071-1072. DOI: 10.1016/J.Addr.2007.08.010 |
0.01 |
|
| 2006 |
Phillips KS, Han JH, Martinez M, Wang Z, Carter D, Cheng Q. Nanoscale glassification of gold substrates for surface plasmon resonance analysis of protein toxins with supported lipid membranes. Analytical Chemistry. 78: 596-603. PMID 16408945 DOI: 10.1021/Ac051644Y |
0.01 |
|
| 2006 |
Martinez M, McDermott P, Walker R. Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals. Veterinary Journal (London, England : 1997). 172: 10-28. PMID 16154368 DOI: 10.1016/j.tvjl.2005.07.010 |
0.01 |
|
| 2006 |
MARTINEZ MN. WS05 Regulatory efforts to minimize the selection of resistant bacteria Journal of Veterinary Pharmacology and Therapeutics. 29: 29-29. DOI: 10.1111/J.1365-2885.2006.00773_5.X |
0.01 |
|
| 2006 |
MARTINEZ MN. RT07 Understanding advantages and limitations of pre-clinical studies for dose selection Journal of Veterinary Pharmacology and Therapeutics. 29: 18-19. DOI: 10.1111/J.1365-2885.2006.00772_2.X |
0.01 |
|
| 2005 |
Martinez M, Soback S. Preface: challenges and issues in veterinary pharmacology and animal health - 2005. The Aaps Journal. 7: E266-71. PMID 16353907 DOI: 10.1208/aapsj070226 |
0.01 |
|
| 2005 |
Russek-Cohen E, Martinez MN, Nevius AB. A SAS/IML program for simulating pharmacokinetic data. Computer Methods and Programs in Biomedicine. 78: 39-60. PMID 15780889 DOI: 10.1016/J.Cmpb.2004.10.007 |
0.01 |
|
| 2004 |
Rathbone MJ, Martinez M. Veterinary drug delivery: Part VI. Advanced Drug Delivery Reviews. 56: 1339-44. PMID 15191785 DOI: 10.1016/j.addr.2004.04.001 |
0.01 |
|
| 2003 |
Martinez MN, McGilveray I. AAPS/RAPS/CAPRA collaborative program: exploring the challenges of drug regulation in a global environment: clinical concerns. Aaps Pharmsci. 5: E27. PMID 15198515 DOI: 10.1208/ps050427 |
0.01 |
|
| 2002 |
Martinez M, Soback S. Introduction: a welcome to the First Special Animal Health Issue of AAPS PharmSci. Aaps Pharmsci. 4: E39. PMID 12647740 |
0.01 |
|
| 2002 |
Martinez M, Rathbone MJ. Linking human and veterinary health: trends, directions and initiatives. Aaps Pharmsci. 4: E32. PMID 12646004 DOI: 10.1208/ps040432 |
0.01 |
|
| 2002 |
Rathbone MJ, Martinez MN. Modified release drug delivery in veterinary medicine. Drug Discovery Today. 7: 823-9. PMID 12546970 |
0.01 |
|
| 2002 |
Creticos PS, Adams WP, Petty BG, Lewis LD, Singh GJ, Khattignavong AP, Molzon JA, Martinez MN, Lietman PS, Williams RL. A methacholine challenge dose-response study for development of a pharmacodynamic bioequivalence methodology for albuterol metered- dose inhalers. The Journal of Allergy and Clinical Immunology. 110: 713-20. PMID 12417879 DOI: 10.1067/mai.2002.129036 |
0.01 |
|
| 2002 |
Martinez M, Amidon G, Clarke L, Jones WW, Mitra A, Riviere J. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part II. Physiological considerations. Advanced Drug Delivery Reviews. 54: 825-50. PMID 12363433 DOI: 10.1016/S0169-409X(02)00071-6 |
0.01 |
|
| 2002 |
Martinez M, Augsburger L, Johnston T, Jones WW. Applying the biopharmaceutics classification system to veterinary pharmaceutical products. Part I: biopharmaceutics and formulation considerations. Advanced Drug Delivery Reviews. 54: 805-24. PMID 12363432 DOI: 10.1016/S0169-409X(02)00070-4 |
0.01 |
|
| 2002 |
Martinez MN, Amidon GL. A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals. Journal of Clinical Pharmacology. 42: 620-43. PMID 12043951 DOI: 10.1177/00970002042006005 |
0.01 |
|
| 1994 |
MARTINEZ MN, RIVIERE JE. Review of the 1993 Veterinary Drug Bioequivalence Workshop Journal of Veterinary Pharmacology and Therapeutics. 17: 85-119. DOI: 10.1111/J.1365-2885.1994.Tb00220.X |
0.01 |
|
| 1991 |
Martinez MN, Jackson AJ. Suitability of Various Noninfinity Area Under the Plasma Concentration–Time Curve (AUC) Estimates for Use in Bioequivalence Determinations: Relationship to AUC from Zero to Time Infinity (AUCO–INF) Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 8: 512-517. PMID 1871049 DOI: 10.1023/A:1015863530888 |
0.01 |
|
| Hide low-probability matches. |